Exclusive
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

India to Complete 10 Lakh Genome Sequencing for Precision Medicine: Union Minister

Written by : Jayati Dubey

February 3, 2025

Category Img

Source: X (Twitter)

Highlighting the transformative potential of genomic advancements, Singh stated that traditional “one-size-fits-all” treatments would soon be replaced with personalized therapies.

India is advancing towards a future of precision medicine with a strong emphasis on genomic research and technology-driven healthcare, Union Minister Jitendra Singh said on Sunday.

Speaking at the inauguration of the Centre for Advanced Genomics and Precision Medicine at AIIMS-Jammu, Singh reaffirmed the government's commitment to completing 10 lakh genome sequencing in the coming years.

This initiative aims to enhance disease prediction and enable personalized medical interventions.

The new center, established in collaboration with 4baseCare, is set to revolutionize personalized medicine by leveraging cutting-edge genomic research.

By integrating individual genetic profiles with advanced treatment methodologies, the facility seeks to improve diagnosis and patient care.

Transforming Healthcare with Genomics

Highlighting the transformative potential of genomic advancements, Singh stated that traditional “one-size-fits-all” treatments would soon be replaced with personalized therapies.

By understanding genetic variations, doctors can tailor treatments for maximum efficacy and specificity, reducing the reliance on trial-and-error approaches in prescribing medications.

The center at AIIMS-Jammu places the institute among the leaders in medical research and precision healthcare in India.

With a strong focus on AI-driven diagnostics and genomic data analysis, the facility will work towards early disease detection, optimized treatment plans, and enhanced patient outcomes.

Experts at the event highlighted that the center will play a pivotal role in advancing precision oncology, cardiovascular genomics, and genetic screening for rare disorders.

The integration of AI and genomics will enable doctors to predict disease risks with greater accuracy and develop targeted therapies based on a patient’s genetic makeup.

India’s Rising Role in Biotech

Jitendra Singh underscored India's technology-driven approach to healthcare, citing the rapid expansion of biotechnology and genomic research under Prime Minister Narendra Modi’s leadership.

He noted that India's bio-economy has grown from $10 billion in 2014 to nearly $130 billion today, with an ambitious target of reaching $300 billion in the near future.

He also highlighted the rise of biotech startups in India, with over 9,000 startups today compared to just 50 in 2014. This exponential growth, he said, is positioning India as a global leader in medical innovation.

Building an India-Specific Genomic Database

Recognizing India's unique genetic diversity, Singh stressed the need for an India-specific genomic database.

“India is a subcontinent in itself, with over 4,600 distinct demographic groups. Our genome sequencing efforts, which have already mapped 10,000 healthy individuals across 99 communities, will create a robust dataset tailored to Indian-specific health challenges,” he explained.

Singh also acknowledged the dual challenge of rising non-communicable diseases and the resurgence of infectious diseases.

He called for a hybrid approach that combines traditional diagnostics with genetic insights to improve healthcare outcomes.

India has already made significant strides in preventive healthcare, pioneering innovations such as the world’s first DNA-based Covid-19 vaccine and the HPV vaccine.

With the launch of this center, India is further strengthening its ability to prevent, diagnose, and treat diseases using cutting-edge genomic technology.

A key objective of the Centre for Advanced Genomics and Precision Medicine is to make precision medicine affordable and accessible to the wider population.

While personalized treatments have traditionally been expensive, AIIMS-Jammu aims to leverage indigenous research and government-backed biotech initiatives to reduce costs and integrate genomic-based treatments into public healthcare programs.

Stay tuned for more such updates on Digital Health News.


POPULAR CATEGORIES

WEEKLY POPULAR POSTS

ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2025